EP Patent

EP0402989A2 — Antifungal 4-[4-[4-[4-[[2-(2,4-difluorophenyl)-2-(1H-azolylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]-1-piperazinyl]phenyl]triazolones and imidazolones

Assigned to Janssen Pharmaceutica NV · Expires 1990-12-19 · 35y expired

What this patent protects

4-[4-[4-[4-[[2-(2,4-difluorophenyl)-2-(1 H -azolylmethyl)-1,3-dioxolan-4-yl]methoxy]­phenyl]-1-piperazinyl]phenyl]triazolones and imidazolones of formula wherein Q is CH or N; Y is a radical of formula R¹ is C₅₋₇cycloalkyl or mono-, di-, tri-, tetra- or pentahaloC₁₋…

USPTO Abstract

4-[4-[4-[4-[[2-(2,4-difluorophenyl)-2-(1 H -azolylmethyl)-1,3-dioxolan-4-yl]methoxy]­phenyl]-1-piperazinyl]phenyl]triazolones and imidazolones of formula wherein Q is CH or N; Y is a radical of formula R¹ is C₅₋₇cycloalkyl or mono-, di-, tri-, tetra- or pentahaloC₁₋₄alkyl; and R² is C₁₋₆alkyl, C₅₋₇cycloalkyl or mono-, di-, tri-, tetra- or pentahaloC₁₋₄alkyl, the acid addition salts and stereoisomeric forms thereof; said compounds having antifungal properties. Pharmaceutical compositions containing such compounds as an active ingredient; methods of preparing said compounds and pharmaceutical compositions.

Drugs covered by this patent

Patent Metadata

Patent number
EP0402989A2
Jurisdiction
EP
Classification
—
Expires
1990-12-19
Drug substance claim
No
Drug product claim
No
Assignee
Janssen Pharmaceutica NV
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.